[Clinical aspects, diagnosis and therapy of Yersinia enterocolitica infections]. 1990

J A Hoogkamp-Korstanje, and J de Koning
Laboratory for Public Health, Leeuwarden/Niederlande.

The predominant form (65% of all patients) of yersiniosis is mesenteric adenitis, resulting in enteritis, pseudo-appendicular syndromes, ileitis or colitis. The severity of this form depends to some degree on the age. Extra-mesenteric forms (in 20-25%), focal infections by dissemination, the septic form and the lymphadenopathy syndrome may occur after or without previous enteritis. Persistence of Y. enterocolitica in lymphnodes and the GALT is responsible for chronic and recurrent forms. Secondary immunological complications (25%) are arthritis and Erythema nodosum. Diagnosis is made by culture, serology, of which demonstration of specific antibodies against released proteins is more reliable than demonstration of agglutinins and antigen detection by indirect immunofluorescence in biopsies. Antibiotic treatment of mild enteric forms is questionable, extra-mesenteric forms should be treated. Appropriate antibiotics are trimethoprim, chloramphenicol, tetracycline and the new fluoroquinolones. Studies are in progress (Leeuwarden and Hanover, MHH) to elucidate the indication of antibiotic treatment of Yersinia-arthritis patients.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D015008 Yersinia enterocolitica A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children. Bacterium enterocoliticum
D015009 Yersinia Infections Infections with bacteria of the genus YERSINIA. Yersinia Infection,Infections, Yersinia,Yersinia enterocolitica Infection,Yersiniosis,Infection, Yersinia,Yersinia enterocolitica Infections,Yersinioses

Related Publications

J A Hoogkamp-Korstanje, and J de Koning
January 1973, Wiadomosci lekarskie (Warsaw, Poland : 1960),
J A Hoogkamp-Korstanje, and J de Koning
March 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J A Hoogkamp-Korstanje, and J de Koning
January 1979, Contributions to microbiology and immunology,
J A Hoogkamp-Korstanje, and J de Koning
January 1981, Bulletin et memoires de l'Academie royale de medecine de Belgique,
J A Hoogkamp-Korstanje, and J de Koning
January 1978, Nordisk veterinaermedicin,
J A Hoogkamp-Korstanje, and J de Koning
January 1986, Scandinavian journal of infectious diseases,
J A Hoogkamp-Korstanje, and J de Koning
December 1981, La Nouvelle presse medicale,
J A Hoogkamp-Korstanje, and J de Koning
December 1987, Ugeskrift for laeger,
J A Hoogkamp-Korstanje, and J de Koning
August 1981, Recenti progressi in medicina,
J A Hoogkamp-Korstanje, and J de Koning
April 1987, The Indian journal of medical research,
Copied contents to your clipboard!